-
公开(公告)号:US20130210728A1
公开(公告)日:2013-08-15
申请号:US13518617
申请日:2010-12-17
申请人: Rafael Simó Canonge , Cristina Hernández Pascual , Jimena Fernández Carneado , Marc Gómez Caminals , RIbera Jordana I Lluch , Josep Farrera Sinfreu , Berta Ponsati Obiols
发明人: Rafael Simó Canonge , Cristina Hernández Pascual , Jimena Fernández Carneado , Marc Gómez Caminals , RIbera Jordana I Lluch , Josep Farrera Sinfreu , Berta Ponsati Obiols
IPC分类号: A61K38/31
CPC分类号: A61K38/31 , A61K9/0048 , A61K9/08 , A61K9/127 , A61K9/5153 , A61K47/02 , A61K47/54 , A61K47/60
摘要: A topical ophthalmic formulation of peptides and their use for the treatment and/or local prevention of ocular diseases, preferably posterior segment eye diseases.
摘要翻译: 肽的局部眼用制剂及其用于治疗和/或局部预防眼部疾病,优选后段眼疾病的用途。
-
公开(公告)号:US09216208B2
公开(公告)日:2015-12-22
申请号:US13518617
申请日:2010-12-17
申请人: Rafael Simó Canonge , Cristina Hernández Pascual , Jimena Fernández Carneado , Marc Gómez Caminals , Rlbera Jordana I Lluch , Josep Farrera Sinfreu , Berta Ponsati Obiols
发明人: Rafael Simó Canonge , Cristina Hernández Pascual , Jimena Fernández Carneado , Marc Gómez Caminals , Rlbera Jordana I Lluch , Josep Farrera Sinfreu , Berta Ponsati Obiols
CPC分类号: A61K38/31 , A61K9/0048 , A61K9/08 , A61K9/127 , A61K9/5153 , A61K47/02 , A61K47/54 , A61K47/60
摘要: A topical ophthalmic formulation of peptides and their use for the treatment and/or local prevention of ocular diseases, preferably posterior segment eye diseases.
摘要翻译: 肽的局部眼用制剂及其用于治疗和/或局部预防眼部疾病,优选后段眼疾病的用途。
-
公开(公告)号:US08946154B2
公开(公告)日:2015-02-03
申请号:US13319285
申请日:2010-05-06
申请人: Antonio Parente Dueña , Berta Ponsati Obiols , Jimena Fernández Carneado , Marc Gómez Caminals , Ribera Jordana I Lluch
发明人: Antonio Parente Dueña , Berta Ponsati Obiols , Jimena Fernández Carneado , Marc Gómez Caminals , Ribera Jordana I Lluch
IPC分类号: A61K38/31 , A61K38/22 , C07K14/655 , C07K14/575 , G01N33/74 , A61K38/00
CPC分类号: G01N33/74 , A61K38/00 , C07K14/655 , G01N2333/655
摘要: Peptide derivatives, their stereoisomers, mixtures thereof and/or their pharmaceutically acceptable salts, a method of obtaining them, pharmaceutical compositions containing them and the use thereof for the treatment, prevention and/or diagnosis of those conditions, disorders and/or pathologies in which the sstr1, sstr2, sstr3, sstr4 and/or sstr5 somatostatin receptors are expressed.
摘要翻译: 肽衍生物,其立体异构体,其混合物和/或其药学上可接受的盐,获得它们的方法,含有它们的药物组合物及其用于治疗,预防和/或诊断这些病症,病症和/或病症的用途,其中 表达sstr1,sstr2,sstr3,sstr4和/或sstr5生长抑素受体。
-
-